Back to results
US 2010/0137332 A1Published application
Piperazine modulators of nk-1 receptors
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Manouchehr M. Shahbaz
Life of this patent
Estimating the term…
Abstract
The present invention relates to new piperazine modulators of NK-1 receptors, pharmaceutical compositions thereof, and methods of use thereof.
Claims39
A compound of structural Formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1-R35 are independently selected from the group consisting of hydrogen and deuterium;
- and
- at least one of R1-R35 is deuterium.
1 more element
Dependencies are inferred from the claim text.